These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7291244)

  • 1. Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?
    Kuczenski R; Leith NJ
    Pharmacol Biochem Behav; 1981 Sep; 15(3):405-13. PubMed ID: 7291244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic amphetamine: tolerance and reverse tolerance reflect different behavioral actions of the drug.
    Leith NJ; Kuczenski R
    Pharmacol Biochem Behav; 1981 Sep; 15(3):399-404. PubMed ID: 7291243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics.
    Kuczenski R; Segal DS; Aizenstein ML
    J Neurosci; 1991 Sep; 11(9):2703-12. PubMed ID: 1715389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.
    Robinson TE; Camp DM
    Pharmacol Biochem Behav; 1987 Apr; 26(4):821-7. PubMed ID: 2440058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism.
    Kuczenski R
    J Pharmacol Exp Ther; 1980 Oct; 215(1):135-42. PubMed ID: 6109012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of sensitization to amphetamine and dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal cortex.
    Hedou G; Homberg J; Feldon J; Heidbreder CA
    Neuropharmacology; 2001 Mar; 40(3):366-82. PubMed ID: 11166330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis.
    Kuczenski R; Segal D
    J Neurosci; 1989 Jun; 9(6):2051-65. PubMed ID: 2566664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.
    Robinson TE; Becker JB
    Brain Res; 1986 Jun; 396(2):157-98. PubMed ID: 3527341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
    Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
    Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies.
    Wan RQ; Giovanni A; Kafka SH; Corbett R
    Behav Brain Res; 1996 Aug; 78(2):211-23. PubMed ID: 8864054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis.
    Segal DS; Kuczenski R; Okuda C
    Pharmacol Biochem Behav; 1992 Jul; 42(3):421-9. PubMed ID: 1409775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments.
    Kuczenski R; Segal DS; Todd PK
    Psychopharmacology (Berl); 1997 Dec; 134(3):221-9. PubMed ID: 9438672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover.
    Kuczenski R
    Brain Res; 1979 Mar; 164():217-25. PubMed ID: 154937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1997 Aug; 767(1):34-44. PubMed ID: 9365013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
    Barnett JV; Kuczenski R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.
    Robinson TE; Jurson PA; Bennett JA; Bentgen KM
    Brain Res; 1988 Oct; 462(2):211-22. PubMed ID: 2847849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation.
    Conti LH; Segal DS; Kuczenski R
    Psychopharmacology (Berl); 1997 Mar; 130(2):183-8. PubMed ID: 9106917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.
    Paulson PE; Camp DM; Robinson TE
    Psychopharmacology (Berl); 1991; 103(4):480-92. PubMed ID: 2062986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
    Wunderlich GR; DeSousa NJ; Vaccarino FJ
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.